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that this cytotoxic agent has a useful place in the treatment of other cases of intra-epithelial carcinoma of the vagina. The case underlines the need for regular cytological examination of the cervix and vagina in all female patients receiving longterm immunosuppressive therapy. REFERENCES McKhan C F (1969) First seen at the age of 131 because of short stature and absence of secondary sexual characteristics. The diagnosis of Turner's syndrome was confirmed by cytogenetic studies and she was prescribed a regime of high-dose cyclic aestrogen therapy: 0.1 mg of ethinyl oestradiol daily for the first nine months and after that 0.1 mg of ethinyl cestradiol daily for three weeks out of four. After 41 years she experienced four episodes of moderately severe mid-cycle breakthrough bleeding. An examination under anesthesia and curettage of the uterine cavity revealed a single large endocervical polyp plus abundant endometrial tissue. The histopathology of the endometrium showed the classical 'Swiss cheese' pattern of cystic glandular hyperplasia.
Comment
This case is of concern because it is an iatrogenic complication and because cystic glandular hyperplasia is considered to be a precancerous lesion (Gusberg & Hall 1961 , Gusberg et al. 1954 , Meissner et al. 1957 . It is pertinent because cystic glandular hyperplasia and adenocarcinoma of the endometrium has not been considered a problem in patients with gonadal dysgenesis until very recently (Cutler et al. 1972 ).
There are several reports in the literature concerning the development of adenocarcinoma of the endometrium in patients with Turner's syndrome treated with diethyl stilboestrol (Cutler et al. 1972 , Canlorbe et al. 1967 , Dowsett 1963 , Scott 1967 , Wilkinson et al. 1973 ). In every case except one the duration of therapy was five years or more. The average age of these patients at the time of diagnosis was 30.9 years, while the average duration of therapy was 10.1 years. These reports become significant when one considers that a review of the English literature produced only two cases of spontaneous endometrial carcinoma in untreated patients who had dysgenetic gonads (Gray et al. 1970 , Lewis et al. 1963 . Also, the mean age of the affected group is significantly below the mean age of 55 years for adenocarcinoma in the genetically normal population.
In our clinic, 12 patients with dysgenetic gonads had undergone diagnostic curettage. Seven received exclusively ethinyl cestradiol cyclically. The rest received a combination of ethinyl cestradiol and some form of progestogen in the latter half of the cycle. Four of the 7 patients treated with ethinyl cestradiol alone showed changes of cystic glandular hyperplasia. None of the patients treated with a combined regime of cyclic hormonal therapy revealed any microscopic abnormality of the endometrium. The average age at diagnosis of the group with cystic glandular hyperplasia was 22.2 years and the average duration of therapy was only 3.9 years. Thus there is an unusually high incidence of cystic glandular hyperplasia in young patients with gonadal dysgenesis who had undergone a relatively short course of aestrogen therapy.
A number of reports in the literature suggest that the prolonged and unopposed action of cestrogen may be associated with the genesis of endometrial adenocarcinoma (Gusberg & Hall 1961 , Vass 1949 , Jensen & 0stergaard 1954 , Wallach & Henneman 1959 . This theory of cestrogen induction is further substantiated on clinical grounds by cases in which there is a persistent endogenous cestrogen production (Jackson & Dockerty 1957 , Chamlain & Taylor 1970 , Andrews & Andrews 1960 , Dockerty & Mussey 1961 , Greene 1957 , Ingram & Novak 1951 , Mansell & Hertig 1955 , Larson 1954 . Moreover, work on females who had received unusually prolonged cestrogen therapy showed clearly the progression of changes in the endometrium from cystic glandular hyperplasia to adenomatous hyperplasia and eventually to adenocarcinoma (Gusberg & Hall 1961 , Gusberg et al. 1954 , Meissner et al. 1957 , Vass 1949 , Fremont-Smith et al. 1946 , Gusberg 1947 , Hertig, Sommers & Bengloff 1949 . The fact that in patients with cystic glandular hyperplasia the duration of therapy was less than half and the average age at diagnosis was almost 10 years less than in the group with adenocarcinoma further illustrates the adverse effect of prolonged, unopposed cestrogenic stimulation of the endometrium, and its possible close association with the genesis of endometrial carcinoma.
The following conclusions may be drawn from this case report:
(1) The use of cestrogens in cases of gonadal dysgenesis is possibly an iatrogenic model of carcinoma induction in the endometrium.
(2) Long-term, high-dose unopposed oestrogen therapy in such patients is to be condemned.
(3) Low-dose cyclic cestrogen therapy with the addition of the cyclic use of a progestogen is recommended. Cyclic progestogen therapy will mature 'estrogen-induced' endometrium and may thereby prevent hyperplasia and the possible induction of endometrial carcinoma. (1957) In July 1971 a woman aged 37 had a bilateral tubal re-implantation performed to reverse a tubal ligation. She was English, divorced from her African husband by whom she had had four children and was engaged to another African. The tubal implantation was complicated by a pelvic abscess and eventually a hysterectomy for menorrhagia. Following this she developed hemorrhagic cystitis.
During a cystoscopy the urologist noticed that she had ulceration at the vaginal vault and as she continued to bleed vaginally during the following week she was transferred to our care. At examination under anesthesia a week later she was found to have several shallow sinuses at the vaginal vault and in the anterior vaginal wall. No treatment was given. Two weeks later she was found to have a large indurated ulcer on the right side of the vagina, the sinuses having healed. A biopsy was taken which showed granulation tissue with necrosis. Vaginal swabs grew, at various times, E. coli, Strep. fwecalis, klebsiella and Candida albicans. Cultures for tubercle bacilli and fungi were negative. A barium enema showed no evidence of Crohn's disease.
She developed further bleeding which was arrested by suturing the ulcer. This, however, did not heal.
At a fourth examination under anasthesia it was decided that this could be a self-inflicted lesion. The labia majora were sutured together with silk and a Foley catheter inserted. A week later the ulcer had healed. We considered that this proved the diagnosis of self-mutilation.
Discussion
Battle & Pollitt (1964) have classified patients who mutilate themselves into those with and those without conscious motive. Patients without motive may be psychotic or neurotic. The psychosis may be mania, schizophrenia or severe depression. The injuries tend to be impulsive and savage. Neurotic patients tend to disguise and conceal their injuries and modus operandi. These patients should not be too readily challenged as this may jeopardize the therapeutic relationship.
The other main group is of those with conscious motive. There are the well-known army recruits who do not wish to fight. However, these
